FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Real-time Boerse Frankfurt Warrants 16:58:27 03/06/2024 BST | ||
| 1.66 EUR | -7.78% |
|
| 1 month | -16.28% | ||
| 3 months | -26.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.66 | -7.78% |
| 31/05/24 | 1.8 | +9.76% |
| 30/05/24 | 1.64 | -5.75% |
| 29/05/24 | 1.74 | +1.16% |
| 28/05/24 | 1.72 | +5.52% |
Real-time Boerse Frankfurt Warrants
Last update June 03, 2024 at 04:58 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12L2 |
| ISIN | DE000SV12L22 |
| Date issued | 15/03/2023 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.02 € |
|---|---|
| Lowest since issue | 1.15 € |
| Spread | 0.01 € |
| Spread % | 0.60% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Certificates
- Certificat
